findmyKOL

Directory

KOLs working with Dana-Farber Cancer Institute

33 key opinion leaders with clinical trial sponsorships or reported industry payments from Dana-Farber Cancer Institute. Relationships are drawn from ClinicalTrials.gov sponsor records and CMS Open Payments, with every number cited to its source.

The 24 most cited

Edward Giovannucci, MD, ScD, MPH

Harvard T.H. Chan School of Public Health

Active 2026
Enriched profileEpidemiologyEpidemiology / Public HealthNortheast · MA
2,896
publications
217
h-index
2
trials
View profile →

Paul Richardson, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologyNortheast · MA
2,062
publications
172
h-index
17
trials
View profile →

Eric Winer, MD

Yale School of Medicine

Active 2026
Enriched profileBreastMedical OncologyNortheast · CT
1,624
publications
171
h-index
20
trials
View profile →

Toni Choueiri, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileGenitourinaryMedical OncologyNortheast · MA
2,494
publications
152
h-index
12
trials
View profile →

Pasi Janne, MD, PhD

Dana-Farber Cancer Institute

Active 2026
Enriched profileLungMedical OncologyNortheast · MA
2,385
publications
163
h-index
15
trials
View profile →

Charles Fuchs, MD, MPH

Tubulis GmbH

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileGastrointestinalMedical OncologyNortheast · MA
1,721
publications
172
h-index
7
trials
View profile →

Nikhil Munshi, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologyNortheast · MA
1,801
publications
152
h-index
8
trials
View profile →

Patrick Wen, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profileNeuro-OncologyMedical OncologyNortheast · MA
1,915
publications
146
h-index
27
trials
View profile →

Richard Stone, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyNortheast · MA
1,851
publications
133
h-index
13
trials
View profile →

Joaquim Bellmunt, MD, PhD

Dana-Farber Cancer Institute

Active 2026
Enriched profileGenitourinaryMedical OncologyNortheast · MA
1,139
publications
107
h-index
9
trials
View profile →

George Demetri, MD

Dana-Farber Cancer Institute; Professor of Medicine

Active 2026
Enriched profileSarcomaMedical OncologyNortheast
637
publications
115
h-index
10
trials
View profile →

David Reardon, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profileNeuro-OncologyHematology / OncologyNortheast · MA
1,226
publications
121
h-index
28
trials
View profile →

Geoffrey Shapiro, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLungMedical OncologyNortheast · MA
2,055
publications
116
h-index
24
trials
View profile →

Shalender Bhasin, MD

Brigham and Women's Hospital

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileEndocrinology/MetabolicEndocrinology, Diabetes & MetabolismNortheast · MA
664
publications
102
h-index
24
trials
View profile →

Jeffrey Meyerhardt, MD, MPH

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileGastrointestinalMedical OncologyNortheast · MA
1,086
publications
119
h-index
11
trials
View profile →

David Hong, MD

The University of Texas MD Anderson Cancer Center

Active 2026
Enriched profileLungMedical OncologySouth Central · TX
1,978
publications
107
h-index
42
trials
View profile →

Ann Partridge, MD, MPH

Dana-Farber Cancer Institute

Active 2026
Enriched profileBreastMedical OncologyNortheast
1,042
publications
102
h-index
11
trials
View profile →

Irene Ghobrial, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologyNortheast · MA
1,125
publications
101
h-index
16
trials
View profile →

Corey Cutler, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematologyNortheast · MA
834
publications
106
h-index
13
trials
View profile →

Patrick Ott, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMelanomaMedical OncologyNortheast · MA
616
publications
82
h-index
8
trials
View profile →

Daniel Deangelo, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyNortheast · MA
933
publications
93
h-index
10
trials
View profile →

Sara Tolaney, MD, MPH

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileBreastHematology / OncologyNortheast · MA
1,337
publications
85
h-index
22
trials
View profile →

Brian Wolpin, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileGastrointestinalMedical OncologyNortheast · MA
1,250
publications
89
h-index
5
trials
View profile →

Vincent Ho, MD

Dana-Farber Cancer Institute

Active 2026
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaMedical OncologyNortheast · MA
667
publications
86
h-index
12
trials
View profile →

Filter, sort, and export all 33 working with Dana-Farber Cancer Institute in the directory